Trial intelligence / Profile preview

Skin immune system changes in hidradenitis suppurativa during biologic therapy

NL-OMON49777Not yet recruiting

Sponsor
Erasmus MC
Start
Jul 2020
Countries
1
01

Overview

Open-label, single-arm trial in hidradenitis suppurativa (HS), sponsored by Erasmus MC. Primary endpoint: Change in gene expression profile. Planned start Jul 2020; status: not yet recruiting.

02

Conditions

hidradenitis suppurativa (HS)

Beyond the preview

Go deeper on NL-OMON49777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call